Compile Data Set for Download or QSAR

Found 165 hits Enz. Inhib. hit(s) with all data for entry = 1310   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316174 (N-(3-((1H-benzo[d]imidazol-1-yl)methyl)-4-(4-methy...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(N3CCN(C)CC3)c(Cn3cnc4ccccc34)c2)ncn1 Show InChI InChI=1S/C30H31N7O/c1-35-13-15-36(16-14-35)27-12-11-23(17-22(27)19-37-21-33-25-8-4-5-9-28(25)37)34-30-18-26(31-20-32-30)24-7-3-6-10-29(24)38-2/h3-12,17-18,20-21H,13-16,19H2,1-2H3,(H,31,32,34)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM5655 (2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydr...) Show SMILES CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl |r| Show InChI InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL DrugBank MCE MMDB PC cid PC sid PDB UniChem Patents Similars	DrugBank MMDB PDB US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair				3D Structure (crystal)
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316179 (2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(Cl)c(c2)C(=O)NN)ncn1 Show InChI InChI=1S/C18H16ClN5O2/c1-26-16-5-3-2-4-12(16)15-9-17(22-10-21-15)23-11-6-7-14(19)13(8-11)18(25)24-20/h2-10H,20H2,1H3,(H,24,25)(H,21,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316181 (N-(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-yla...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1NS(C)(=O)=O Show InChI InChI=1S/C19H20N4O4S/c1-26-17-7-5-4-6-14(17)15-11-19(21-12-20-15)22-13-8-9-18(27-2)16(10-13)23-28(3,24)25/h4-12,23H,1-3H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316182 ((2-methoxy-5-(6-(2-methoxyphenyl) pyrimidin-4-ylam...) Show SMILES CNS(=O)(=O)Nc1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1OC Show InChI InChI=1S/C19H21N5O4S/c1-20-29(25,26)24-16-10-13(8-9-18(16)28-3)23-19-11-15(21-12-22-19)14-6-4-5-7-17(14)27-2/h4-12,20,24H,1-3H3,(H,21,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316188 (N-(3-((1H-benzo[d]imidazol-1- yl)methyl)-4-chlorop...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(Cl)c(Cn3cnc4ccccc34)c2)ncn1 Show InChI InChI=1S/C25H20ClN5O/c1-32-24-9-5-2-6-19(24)22-13-25(28-15-27-22)30-18-10-11-20(26)17(12-18)14-31-16-29-21-7-3-4-8-23(21)31/h2-13,15-16H,14H2,1H3,(H,27,28,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316189 ((5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-(4-m...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(N3CCN(C)CC3)c(CO)c2)ncn1 Show InChI InChI=1S/C23H27N5O2/c1-27-9-11-28(12-10-27)21-8-7-18(13-17(21)15-29)26-23-14-20(24-16-25-23)19-5-3-4-6-22(19)30-2/h3-8,13-14,16,29H,9-12,15H2,1-2H3,(H,24,25,26)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316202 (US10294218, Example 30 | US9617225, Example 30 | m...) Show SMILES COC(=O)c1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1OC Show InChI InChI=1S/C20H19N3O4/c1-25-17-7-5-4-6-14(17)16-11-19(22-12-21-16)23-13-8-9-18(26-2)15(10-13)20(24)27-3/h4-12H,1-3H3,(H,21,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316204 (2-methoxy-5-(6-(2- methoxyphenyl)pyrimidin-4- ylam...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1O Show InChI InChI=1S/C18H17N3O3/c1-23-16-6-4-3-5-13(16)14-10-18(20-11-19-14)21-12-7-8-17(24-2)15(22)9-12/h3-11,22H,1-2H3,(H,19,20,21)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316205 (2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C(=O)NN Show InChI InChI=1S/C19H19N5O3/c1-26-16-6-4-3-5-13(16)15-10-18(22-11-21-15)23-12-7-8-17(27-2)14(9-12)19(25)24-20/h3-11H,20H2,1-2H3,(H,24,25)(H,21,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316207 (N-(3-((dimethylamino)methyl)-4-methoxyphenyl)-6-(2...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1CN(C)C Show InChI InChI=1S/C21H24N4O2/c1-25(2)13-15-11-16(9-10-19(15)26-3)24-21-12-18(22-14-23-21)17-7-5-6-8-20(17)27-4/h5-12,14H,13H2,1-4H3,(H,22,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316209 (N-(4-methoxy-3-((methylamino)methyl)phenyl)-6-(2-m...) Show SMILES CNCc1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1OC Show InChI InChI=1S/C20H22N4O2/c1-21-12-14-10-15(8-9-18(14)25-2)24-20-11-17(22-13-23-20)16-6-4-5-7-19(16)26-3/h4-11,13,21H,12H2,1-3H3,(H,22,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316210 (5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-(4-me...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(N3CCN(C)CC3)c(c2)S(N)(=O)=O)ncn1 Show InChI InChI=1S/C22H26N6O3S/c1-27-9-11-28(12-10-27)19-8-7-16(13-21(19)32(23,29)30)26-22-14-18(24-15-25-22)17-5-3-4-6-20(17)31-2/h3-8,13-15H,9-12H2,1-2H3,(H2,23,29,30)(H,24,25,26)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316211 (N-(3-((1H-benzo[d]imidazol-1-yl)methyl)-4-ethoxyph...) Show SMILES CCOc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1Cn1cnc2ccccc12 Show InChI InChI=1S/C27H25N5O2/c1-3-34-25-13-12-20(14-19(25)16-32-18-30-22-9-5-6-10-24(22)32)31-27-15-23(28-17-29-27)21-8-4-7-11-26(21)33-2/h4-15,17-18H,3,16H2,1-2H3,(H,28,29,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316212 (N-(3-((1H-benzo[d]imidazol-1-yl)methyl)-4-fluoroph...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(F)c(Cn3cnc4ccccc34)c2)ncn1 Show InChI InChI=1S/C25H20FN5O/c1-32-24-9-5-2-6-19(24)22-13-25(28-15-27-22)30-18-10-11-20(26)17(12-18)14-31-16-29-21-7-3-4-8-23(21)31/h2-13,15-16H,14H2,1H3,(H,27,28,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316227 (N-{2-Methoxy-5-[6-(2-methoxy-phenyl)-pyrimidin-4-y...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1NC=O Show InChI InChI=1S/C19H18N4O3/c1-25-17-6-4-3-5-14(17)15-10-19(21-11-20-15)23-13-7-8-18(26-2)16(9-13)22-12-24/h3-12H,1-2H3,(H,22,24)(H,20,21,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	KEGG PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316285 (2-Dimethylamino-5-[6-(4-fluoro-2-methoxy-phenyl)-p...) Show SMILES COc1cc(F)ccc1-c1cc(Nc2ccc(N(C)C)c(c2)C(N)=O)ncn1 Show InChI InChI=1S/C20H20FN5O2/c1-26(2)17-7-5-13(9-15(17)20(22)27)25-19-10-16(23-11-24-19)14-6-4-12(21)8-18(14)28-3/h4-11H,1-3H3,(H2,22,27)(H,23,24,25)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316288 (US10294218, Example 116 | US9617225, Example 116 |...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(OC)c(c2)C2=CCNCC2)ncn1 |t:22| Show InChI InChI=1S/C23H24N4O2/c1-28-21-6-4-3-5-18(21)20-14-23(26-15-25-20)27-17-7-8-22(29-2)19(13-17)16-9-11-24-12-10-16/h3-9,13-15,24H,10-12H2,1-2H3,(H,25,26,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316293 (2-Methoxy-4-[6-(2-methoxy-phenyl)-pyrimidin-4-ylam...) Show SMILES COc1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1O Show InChI InChI=1S/C18H17N3O3/c1-23-16-6-4-3-5-13(16)14-10-18(20-11-19-14)21-12-7-8-15(22)17(9-12)24-2/h3-11,22H,1-2H3,(H,19,20,21)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316301 (5-[6-(2-Ethoxy-phenyl)-pyrimidin-4- ylamino]-2-met...) Show SMILES CCOc1ccccc1-c1cc(Nc2ccc(OC)c(c2)C(N)=O)ncn1 Show InChI InChI=1S/C20H20N4O3/c1-3-27-18-7-5-4-6-14(18)16-11-19(23-12-22-16)24-13-8-9-17(26-2)15(10-13)20(21)25/h4-12H,3H2,1-2H3,(H2,21,25)(H,22,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316302 (5-[6-(2-Ethoxy-4-fluoro-phenyl)- pyrimidin-4-ylami...) Show SMILES CCOc1cc(F)ccc1-c1cc(Nc2ccc(OC)c(c2)C(N)=O)ncn1 Show InChI InChI=1S/C20H19FN4O3/c1-3-28-18-8-12(21)4-6-14(18)16-10-19(24-11-23-16)25-13-5-7-17(27-2)15(9-13)20(22)26/h4-11H,3H2,1-2H3,(H2,22,26)(H,23,24,25)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM7585 ((R,S)-Roscovitine | 2,6,9-Trisubstituted purine de...) Show SMILES CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1 Show InChI InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL PC cid PC sid PDB UniChem Patents Similars	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316203 (N-(3-((1H-benzo[d]imidazol-1- yl)methyl)-4-methoxy...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1Cn1cnc2ccccc12 Show InChI InChI=1S/C26H23N5O2/c1-32-24-12-11-19(13-18(24)15-31-17-29-21-8-4-5-9-23(21)31)30-26-14-22(27-16-28-26)20-7-3-6-10-25(20)33-2/h3-14,16-17H,15H2,1-2H3,(H,27,28,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316217 (2-methoxy-5-(6-(2- methoxyphenyl)pyrimidin-4- ylam...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C(N)=O |$;;;;;;HN;;;;;;;;;;;;;;;;;;;$| Show InChI InChI=1S/C19H18N4O3/c1-25-16-6-4-3-5-13(16)15-10-18(22-11-21-15)23-12-7-8-17(26-2)14(9-12)19(20)24/h3-11H,1-2H3,(H2,20,24)(H,21,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316176 (N-(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-yla...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1CNS(C)(=O)=O Show InChI InChI=1S/C20H22N4O4S/c1-27-18-9-8-15(10-14(18)12-23-29(3,25)26)24-20-11-17(21-13-22-20)16-6-4-5-7-19(16)28-2/h4-11,13,23H,12H2,1-3H3,(H,21,22,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316172 (N-(3-((benzylamino)methyl)-4-methoxyphenyl)-6-(2-m...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1CNCc1ccccc1 Show InChI InChI=1S/C26H26N4O2/c1-31-24-13-12-21(14-20(24)17-27-16-19-8-4-3-5-9-19)30-26-15-23(28-18-29-26)22-10-6-7-11-25(22)32-2/h3-15,18,27H,16-17H2,1-2H3,(H,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316175 (2-(2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-yla...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1CN1C(=O)c2ccccc2C1=O Show InChI InChI=1S/C27H22N4O4/c1-34-23-12-11-18(13-17(23)15-31-26(32)19-7-3-4-8-20(19)27(31)33)30-25-14-22(28-16-29-25)21-9-5-6-10-24(21)35-2/h3-14,16H,15H2,1-2H3,(H,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316177 (N1-(6-(2-methoxyphenyl)pyrimidin-4-yl)- N4,N4-dime...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(cc2)N(C)C)ncn1 Show InChI InChI=1S/C19H20N4O/c1-23(2)15-10-8-14(9-11-15)22-19-12-17(20-13-21-19)16-6-4-5-7-18(16)24-3/h4-13H,1-3H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316178 ((2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(Cl)c(CO)c2)ncn1 Show InChI InChI=1S/C18H16ClN3O2/c1-24-17-5-3-2-4-14(17)16-9-18(21-11-20-16)22-13-6-7-15(19)12(8-13)10-23/h2-9,11,23H,10H2,1H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316180 (N-(4-methoxy-3-(2-morpholinoethoxy)phenyl)-6-(2-me...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1OCCN1CCOCC1 Show InChI InChI=1S/C24H28N4O4/c1-29-21-6-4-3-5-19(21)20-16-24(26-17-25-20)27-18-7-8-22(30-2)23(15-18)32-14-11-28-9-12-31-13-10-28/h3-8,15-17H,9-14H2,1-2H3,(H,25,26,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316183 (N-(4-methoxy-3-nitrophenyl)-6-(2-methoxyphenyl)pyr...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(OC)c(c2)[N+]([O-])=O)ncn1 Show InChI InChI=1S/C18H16N4O4/c1-25-16-6-4-3-5-13(16)14-10-18(20-11-19-14)21-12-7-8-17(26-2)15(9-12)22(23)24/h3-11H,1-2H3,(H,19,20,21)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316184 (4-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-nitro...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(O)c(c2)[N+]([O-])=O)ncn1 Show InChI InChI=1S/C17H14N4O4/c1-25-16-5-3-2-4-12(16)13-9-17(19-10-18-13)20-11-6-7-15(22)14(8-11)21(23)24/h2-10,22H,1H3,(H,18,19,20)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316185 ((2-methoxy-5-(6-(2-methoxyphenyl) pyrimidin-4-ylam...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1NS(=O)(=O)NC1CCCCC1 |$;;;;;;HN;;;;;;;;;;;;;;;;;;;;;;;;;;;$| Show InChI InChI=1S/C24H29N5O4S/c1-32-22-11-7-6-10-19(22)20-15-24(26-16-25-20)27-18-12-13-23(33-2)21(14-18)29-34(30,31)28-17-8-4-3-5-9-17/h6-7,10-17,28-29H,3-5,8-9H2,1-2H3,(H,25,26,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316186 (US10294218, Example 14 | US9617225, Example 14 | e...) Show SMILES CCOC(=O)c1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1Cl Show InChI InChI=1S/C20H18ClN3O3/c1-3-27-20(25)15-10-13(8-9-16(15)21)24-19-11-17(22-12-23-19)14-6-4-5-7-18(14)26-2/h4-12H,3H2,1-2H3,(H,22,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316187 ((2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(Cl)c(c2)C(=O)N2CCCC2)ncn1 Show InChI InChI=1S/C22H21ClN4O2/c1-29-20-7-3-2-6-16(20)19-13-21(25-14-24-19)26-15-8-9-18(23)17(12-15)22(28)27-10-4-5-11-27/h2-3,6-9,12-14H,4-5,10-11H2,1H3,(H,24,25,26)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316190 (US10294218, Example 18 | US9617225, Example 18 | e...) Show SMILES CCOC(=O)c1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1N1CCOCC1 Show InChI InChI=1S/C24H26N4O4/c1-3-32-24(29)19-14-17(8-9-21(19)28-10-12-31-13-11-28)27-23-15-20(25-16-26-23)18-6-4-5-7-22(18)30-2/h4-9,14-16H,3,10-13H2,1-2H3,(H,25,26,27)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316191 ((5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino)-2-morp...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(N3CCOCC3)c(CO)c2)ncn1 Show InChI InChI=1S/C22H24N4O3/c1-28-21-5-3-2-4-18(21)19-13-22(24-15-23-19)25-17-6-7-20(16(12-17)14-27)26-8-10-29-11-9-26/h2-7,12-13,15,27H,8-11,14H2,1H3,(H,23,24,25)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316193 (US10294218, Example 21 | US9617225, Example 21 | m...) Show SMILES COC(=O)c1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1O Show InChI InChI=1S/C19H17N3O4/c1-25-17-6-4-3-5-13(17)15-10-18(21-11-20-15)22-12-7-8-16(23)14(9-12)19(24)26-2/h3-11,23H,1-2H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316194 (N-(3-fluoro-4-methoxyphenyl)-6-(2-methoxyphenyl)py...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1F Show InChI InChI=1S/C18H16FN3O2/c1-23-16-6-4-3-5-13(16)15-10-18(21-11-20-15)22-12-7-8-17(24-2)14(19)9-12/h3-11H,1-2H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316195 (N-benzyl-2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C(=O)NCc1ccccc1 Show InChI InChI=1S/C26H24N4O3/c1-32-23-11-7-6-10-20(23)22-15-25(29-17-28-22)30-19-12-13-24(33-2)21(14-19)26(31)27-16-18-8-4-3-5-9-18/h3-15,17H,16H2,1-2H3,(H,27,31)(H,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316196 ((2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylami...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1CO Show InChI InChI=1S/C19H19N3O3/c1-24-17-8-7-14(9-13(17)11-23)22-19-10-16(20-12-21-19)15-5-3-4-6-18(15)25-2/h3-10,12,23H,11H2,1-2H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316197 (2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...) Show SMILES CNC(=O)c1cc(Nc2cc(ncn2)-c2ccccc2OC)ccc1OC Show InChI InChI=1S/C20H20N4O3/c1-21-20(25)15-10-13(8-9-18(15)27-3)24-19-11-16(22-12-23-19)14-6-4-5-7-17(14)26-2/h4-12H,1-3H3,(H,21,25)(H,22,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316200 (2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C(=O)NCc1ccncc1 Show InChI InChI=1S/C25H23N5O3/c1-32-22-6-4-3-5-19(22)21-14-24(29-16-28-21)30-18-7-8-23(33-2)20(13-18)25(31)27-15-17-9-11-26-12-10-17/h3-14,16H,15H2,1-2H3,(H,27,31)(H,28,29,30)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316201 (2-methoxy-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamin...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C=O Show InChI InChI=1S/C19H17N3O3/c1-24-17-8-7-14(9-13(17)11-23)22-19-10-16(20-12-21-19)15-5-3-4-6-18(15)25-2/h3-12H,1-2H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316213 (4-methoxy-N1-(6-(2- methoxyphenyl)pyrimidin-4-yl) ...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1N Show InChI InChI=1S/C18H18N4O2/c1-23-16-6-4-3-5-13(16)15-10-18(21-11-20-15)22-12-7-8-17(24-2)14(19)9-12/h3-11H,19H2,1-2H3,(H,20,21,22)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316214 (2-((1H-benzo[d]imidazol-1-yl(methyl)-N4-(6-(2-meth...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(N(C)C)c(Cn3cnc4ccccc34)c2)ncn1 Show InChI InChI=1S/C27H26N6O/c1-32(2)24-13-12-20(14-19(24)16-33-18-30-22-9-5-6-10-25(22)33)31-27-15-23(28-17-29-27)21-8-4-7-11-26(21)34-3/h4-15,17-18H,16H2,1-3H3,(H,28,29,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316215 (N-(3-(aminomethyl)-4- methoxyphenyl)-6-(2- methoxy...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1CN Show InChI InChI=1S/C19H20N4O2/c1-24-17-8-7-14(9-13(17)11-20)23-19-10-16(21-12-22-19)15-5-3-4-6-18(15)25-2/h3-10,12H,11,20H2,1-2H3,(H,21,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316216 (2-chloro-5-(6-(2-methoxyphenyl)pyrimidin-4-ylamino...) Show SMILES COc1ccccc1-c1cc(Nc2ccc(Cl)c(c2)C(N)=O)ncn1 Show InChI InChI=1S/C18H15ClN4O2/c1-25-16-5-3-2-4-12(16)15-9-17(22-10-21-15)23-11-6-7-14(19)13(8-11)18(20)24/h2-10H,1H3,(H2,20,24)(H,21,22,23)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316218 (2-Methoxy-5-[6-(2-methoxy-phenyl)-pyrimidin-4-ylam...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C(=O)N(C)N Show InChI InChI=1S/C20H21N5O3/c1-25(21)20(26)15-10-13(8-9-18(15)28-3)24-19-11-16(22-12-23-19)14-6-4-5-7-17(14)27-2/h4-12H,21H2,1-3H3,(H,22,23,24)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair
Cyclin-dependent kinase 9 (Homo sapiens (Human))	BDBM316219 (2-Methoxy-5-[6-(2-methoxy-phenyl)-pyrimidin-4-ylam...) Show SMILES COc1ccc(Nc2cc(ncn2)-c2ccccc2OC)cc1C(=O)NCCCN1CCN(C)CC1 Show InChI InChI=1S/C27H34N6O3/c1-32-13-15-33(16-14-32)12-6-11-28-27(34)22-17-20(9-10-25(22)36-3)31-26-18-23(29-19-30-26)21-7-4-5-8-24(21)35-2/h4-5,7-10,17-19H,6,11-16H2,1-3H3,(H,28,34)(H,29,30,31)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<1.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
VIROSTATICS SRL US Patent					Assay Description The activity of the compounds described in the present invention can be determined by measuring the phosphorylation of a fluorescently-labeled peptid...				US Patent US9617225 (2017) BindingDB Entry DOI: 10.7270/Q29W0HK6
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 165 total )  |  Next  |  Last  >>

Jump to: